Extracranial Malignant Rhabdoid Tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients must meet all of the following conditions: 1. Age at onset = 60 for patients = 60 for patients >= 16 years of age. 4. Life expectancy of at least 12 weeks. 5. Tumor of non-central nervous system origin (extra-cranial). 6. Voluntary participation of the patient or/and their legal guardian(s), with written informed consent obtained. 7. Newly diagnosed cases (previously untreated).
Exclusion criteria
Exclusion criteria: Participants will be excluded from the study if they meet any of the following criteria: 1. The research participant or their legal guardian(s) is unable or unwilling to provide written informed consent. 2. Presence of a severe congenital anomaly that is potentially life-threatening. 3. The investigator determines that the patient has other severe comorbidities which preclude the ability to undergo chemotherapy or receive anti-angiogenic therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Survival, OS;Event-Free Survival, EFS ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse Event, AE ; | — |
Countries
China
Contacts
Children’s Hospital of Nanjing Medical University